SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 24th, 2023 • Innovation1 Biotech Inc. • Pharmaceutical preparations • Nevada
This Securities Purchase Agreement (this “Agreement”) is dated as of April 13, 2023, by and between Innovation1 Biotech Inc., a Nevada corporation (the “Company”), and each lender party that executes the signature page hereto as a purchaser (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITY AGREEMENTSecurity Agreement • April 24th, 2023 • Innovation1 Biotech Inc. • Pharmaceutical preparations
THIS SECURITY AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) dated as of November 29, 2022, between Innovation1 Biotech Inc., a Nevada corporation (the “Company”) (the Company and each other Person who becomes a party to this Agreement by execution of a joinder in the form of Exhibit A attached hereto, which shall include all wholly-owned or majority-owned subsidiaries of the Company acquired after the date hereof for so long as this Agreement remains in effect, are hereinafter sometimes referred to individually as a “Debtor” and, collectively, as the “Debtors”) and Cavalry Fund I LP, a limited partnership organized and existing under the laws of the State of Delaware, in its capacity as a purchaser and as Collateral Agent for the benefit of itself and each of the other purchasers (together with their respective successors and assigns, each a “Secured Party” and collectively, the “Secured Parties”) who execute this Agreement.
